CT
LLY icon

Caldwell Trust’s Eli Lilly LLY Stock Holding History

Caldwell Trust’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$25.8M Sell
21,550
-182
-0.8% -$186K 2.09% 7
2026
Q1 		$20M Buy
21,732
+437
+2% +$443K 1.79% 8
2025
Q4 		$22.9M Sell
21,295
-21
-0.1% -$20.1K 2.03% 8
2025
Q3 		$16.3M Sell
21,316
-767
-3% -$571K 1.52% 10
2025
Q2 		$17.2M Buy
22,083
+349
+2% +$271K 1.72% 9
2025
Q1 		$18M Sell
21,734
-394
-2% -$328K 1.93% 8
2024
Q4 		$17.1M Buy
22,128
+23
+0.1% +$19K 1.78% 9
2024
Q3 		$19.6M Sell
22,105
-408
-2% -$367K 2.06% 8
2024
Q2 		$20.4M Sell
22,513
-331
-1% -$265K 2.26% 7
2024
Q1 		$17.8M Sell
22,844
-174
-0.8% -$124K 2.07% 8
2023
Q4 		$13.4M Buy
23,018
+140
+0.6% +$81.7K 1.69% 8
2023
Q3 		$12.3M Buy
22,878
+591
+3% +$305K 1.68% 9
2023
Q2 		$10.5M Sell
22,287
-357
-2% -$150K 1.36% 13
2023
Q1 		$7.78M Buy
22,644
+627
+3% +$211K 1.08% 22
2022
Q4 		$8.05M Sell
22,017
-746
-3% -$265K 1.14% 22
2022
Q3 		$7.36M Sell
22,763
-269
-1% -$85.2K 1.09% 20
2022
Q2 		$7.47M Sell
23,032
-57
-0.2% -$17.1K 1.03% 23
2022
Q1 		$6.61M Sell
23,089
-584
-2% -$150K 0.79% 34
2021
Q4 		$6.54M Sell
23,673
-627
-3% -$159K 0.75% 33
2021
Q3 		$5.61M Buy
24,300
+91
+0.4% +$22.5K 0.71% 39
2021
Q2 		$5.56M Sell
24,209
-352
-1% -$70.7K 0.73% 36
2021
Q1 		$4.59M Sell
24,561
-844
-3% -$165K 0.64% 41
2020
Q4 		$4.29M Sell
25,405
-337
-1% -$50.3K 0.65% 42
2020
Q3 		$3.81M Sell
25,742
-1,681
-6% -$260K 0.63% 42
2020
Q2 		$4.5M Sell
27,423
-584
-2% -$89.6K 0.75% 38
2020
Q1 		$3.89M Sell
28,007
-1,189
-4% -$163K 0.74% 41
2019
Q4 		$3.84M Buy
+29,196
New +$3.38M 0.59% 53

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Caldwell Trust's LLY Position: Q2 2026 in Review

Caldwell Trust reduced its Eli Lilly (LLY) stake by 0.84% in Q2 2026, selling an estimated $186K and leaving 21,550 shares worth $25.8M. The position accounts for 2.09% of the portfolio, ranked #7.

Caldwell Trust first reported a position in LLY in Q4 2019 and has held it in 27 quarters since. 4,618 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Caldwell Trust held 21,550 shares of Eli Lilly worth $25.8M as of Q2 2026.
  • Caldwell Trust sold 182 Eli Lilly shares in Q2 2026, an estimated $186K.
  • Eli Lilly made up 2.09% of Caldwell Trust's portfolio in Q2 2026, its #7 holding.
  • Caldwell Trust first reported a position in Eli Lilly in Q4 2019 and has held it in 27 quarters since.
  • 4,618 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Caldwell Trust's 13F filing for Q2 2026, filed 3 Aug 2026.